Stryker ROE 2006-2020 | SYK

Current and historical return on equity (ROE) values for Stryker (SYK) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Stryker ROE for the three months ending March 31, 2020 was 24.90%.
Stryker ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-03-31 $2.16B $13.12B 17.25%
2019-12-31 $2.08B $12.81B 17.09%
2019-09-30 $3.43B $12.32B 28.74%
2019-06-30 $3.55B $11.94B 31.40%
2019-03-31 $3.52B $11.69B 32.96%
2018-12-31 $3.55B $11.73B 35.29%
2018-09-30 $1.24B $9.86B 12.83%
2018-06-30 $1.08B $9.46B 11.05%
2018-03-31 $1.02B $9.22B 10.28%
2017-12-31 $1.02B $9.98B 10.16%
2017-09-30 $1.78B $10.43B 17.92%
2017-06-30 $1.70B $10.04B 17.61%
2017-03-31 $1.69B $9.70B 17.93%
2016-12-31 $1.65B $9.55B 17.91%
2016-09-30 $1.66B $9.33B 18.56%
2016-06-30 $1.61B $9.10B 18.39%
2016-03-31 $1.62B $8.81B 18.85%
2015-12-31 $1.44B $8.51B 17.02%
2015-09-30 $1.18B $8.48B 13.89%
2015-06-30 $0.93B $8.51B 10.96%
2015-03-31 $0.67B $8.32B 7.75%
2014-12-31 $0.52B $8.60B 5.84%
2014-09-30 $0.64B $8.62B 7.17%
2014-06-30 $0.69B $9.00B 7.67%
2014-03-31 $0.77B $9.06B 8.71%
2013-12-31 $1.01B $9.05B 11.55%
2013-09-30 $0.89B $8.74B 10.35%
2013-06-30 $1.14B $8.60B 13.41%
2013-03-31 $1.25B $8.46B 15.01%
2012-12-31 $1.30B $8.60B 15.77%
2012-09-30 $1.43B $8.36B 17.85%
2012-06-30 $1.40B $7.95B 17.98%
2012-03-31 $1.39B $8.02B 17.89%
2011-12-31 $1.35B $7.68B 17.66%
2011-09-30 $1.24B $7.56B 16.54%
2011-06-30 $1.25B $7.78B 16.82%
2011-03-31 $1.26B $7.45B 17.55%
2010-12-31 $1.27B $7.17B 18.25%
2010-09-30 $1.28B $7.31B 18.80%
2010-06-30 $1.18B $6.75B 17.78%
2010-03-31 $1.15B $6.67B 17.82%
2009-12-31 $1.11B $6.60B 17.91%
2009-09-30 $1.08B $6.44B 18.34%
2009-06-30 $1.12B $6.06B 19.69%
2009-03-31 $1.14B $5.63B 19.81%
2008-12-31 $1.15B $5.41B 19.72%
2008-09-30 $1.15B $5.75B 19.71%
2008-06-30 $1.10B $6.22B 19.43%
2008-03-31 $1.07B $5.93B 20.02%
2007-12-31 $1.02B $5.38B 20.54%
2007-09-30 $0.97B $5.16B 20.81%
2007-06-30 $0.93B $4.80B 21.27%
2007-03-31 $0.87B $4.49B 21.27%
2006-12-31 $0.78B $4.19B 20.16%
2006-09-30 $0.73B $3.99B 20.02%
2006-06-30 $0.66B $3.77B 19.34%
2006-03-31 $0.63B $3.49B 19.39%
2005-12-31 $0.64B $3.30B 20.94%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $68.946B $14.884B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $163.141B 28.29
Medtronic (MDT) Ireland $124.955B 20.30
Boston Scientific (BSX) United States $49.509B 23.28
Baxter (BAX) United States $44.233B 0.00
Lonza Group Ag (LZAGY) Switzerland $39.871B 0.00
Terumo (TRUMY) Japan $29.963B 38.30
EssilorLuxottica Societe Anonyme (ESLOY) France $28.693B 0.00
ResMed (RMD) United States $27.846B 43.94
Zimmer Biomet Holdings (ZBH) United States $24.894B 15.66
Smith & Nephew SNATS (SNN) United Kingdom $17.257B 0.00
Sunny Optical Technology (SNPTF) China $16.924B 0.00
Bio-Rad Laboratories (BIO) United States $13.589B 61.86
Insulet (PODD) United States $12.687B 1256.94
DiaSorin S.p.A (DSRLF) Italy $10.994B 0.00
Quidel (QDEL) United States $9.535B 74.93
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
Perrigo (PRGO) Ireland $7.523B 13.46
Hill-Rom Holdings (HRC) United States $7.426B 20.93
GN STORE NORD (GNNDY) Denmark $6.972B 35.54
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.771B 0.00
Haemonetics (HAE) United States $4.656B 27.96
Neogen (NEOG) United States $4.108B 69.58
GW Pharmaceuticals (GWPH) United Kingdom $3.892B 0.00
ICU Medical (ICUI) United States $3.890B 28.38
Agios Pharmaceuticals (AGIO) United States $3.836B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.805B 0.00
Envista Holdings (NVST) United States $3.407B 0.00
NuVasive (NUVA) United States $2.925B 23.49
National Vision Holdings (EYE) United States $2.458B 42.53
TG Therapeutics (TGTX) United States $2.213B 0.00
AtriCure (ATRC) United States $1.855B 0.00
MacroGenics (MGNX) United States $1.450B 0.00
Aurora Cannabis (ACB) Canada $1.390B 0.00
NanoString Technologies (NSTG) United States $1.322B 0.00
Aphria (APHA) Canada $1.231B 0.00
Cardiovascular Systems (CSII) United States $1.137B 0.00
Cerus (CERS) United States $1.109B 0.00
Phibro Animal Health (PAHC) United States $1.055B 21.02
Meridian Bioscience (VIVO) United States $1.019B 38.37
PetIQ (PETQ) United States $1.017B 29.37
DFB Healthcare Acquisitions (AHCO) United States $0.924B 0.00
InMode (INMD) Israel $0.897B 18.97
Vapotherm (VAPO) United States $0.881B 0.00
Zynex (ZYXI) United States $0.834B 83.73
Omeros (OMER) United States $0.826B 0.00
Quanterix (QTRX) United States $0.789B 0.00
OraSure Technologies (OSUR) United States $0.746B 150.25
Eagle Pharmaceuticals (EGRX) United States $0.663B 47.51
Surmodics (SRDX) United States $0.585B 70.49
VAREX IMAGING (VREX) United States $0.584B 14.51
Lantheus Holdings (LNTH) United States $0.579B 11.65
LeMaitre Vascular (LMAT) United States $0.532B 30.29
BioLife Solutions (BLFS) United States $0.467B 163.46
Owens & Minor (OMI) United States $0.464B 12.27
Viemed Healthcare (VMD) United States $0.367B 32.55
Cytosorbents (CTSO) United States $0.361B 0.00
HEXO (HEXO) $0.322B 0.00
Utah Medical Products (UTMD) United States $0.315B 22.85
Neptune Wellness Solutions (NEPT) Canada $0.304B 0.00
Organigram Holdings (OGI) Canada $0.285B 0.00
Female Health (VERU) United States $0.229B 0.00
Chimerix (CMRX) United States $0.196B 0.00
Bovie Medical (APYX) United States $0.185B 0.00
Evolus (EOLS) United States $0.185B 0.00
Surface Oncology (SURF) United States $0.178B 0.00
Exagen (XGN) United States $0.161B 0.00
Fonar (FONR) United States $0.135B 11.94
Rockwell Medical (RMTI) United States $0.133B 0.00
United Health Products (UEEC) United States $0.131B 0.00
Liberty Health Sciences (LHSIF) Canada $0.120B 0.00
Wound Management Technologies (SMTI) United States $0.112B 0.00
MTech Acquisition (KERN) United States $0.109B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.084B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.082B 0.00
Nephros (NEPH) United States $0.073B 0.00
United-Guardian (UG) United States $0.071B 16.51
Capricor Therapeutics (CAPR) United States $0.065B 0.00
Brainsway (BWAY) Israel $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.055B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.012B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00